Back
Stoke Therapeutics 10K Form
Sell
29
STOK
Stoke Therapeutics
Last Price:
11.79
Seasonality Move:
15.29%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive STOK News And Ratings
See the #1 stock for the next 7 days that we like better than STOK
STOK Financial Statistics
Sales & Book Value
Annual Sales: | $8.78M |
---|---|
Cash Flow: | $-17.52M |
Price / Cash Flow: | 0 |
Annual Sales: | $4.64 |
Price / Book: | 2.57 |
Profitability
EPS (TTM): | -2.18000 |
---|---|
Net Income (TTM): | $-103.57M |
Gross Margin: | -- |
Return on Equity: | -57.17% |
Return on Assets: | -41.83% |
Stoke Therapeutics Earnings Forecast
Key Stoke Therapeutics Financial Ratios
- The Research & Development expenses have been 936.57% of Revenue.
- The Net Earning history of STOK is -1,192.47% of Total Revenues.
- Per Share Earnings over the last 7 years have been positive in 2 years.
Stoke Therapeutics Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | STOK |
CUSIP: | 86150R |
Website: | stoketherapeutics.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 6.67 |
Quick Ratio: | 6.34 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
STOK Technical Analysis vs Fundamental Analysis
Sell
29
Stoke Therapeutics (STOK)
is a Sell
Is Stoke Therapeutics a Buy or a Sell?
-
Stoke Therapeutics stock is rated a Sell
The current Stoke Therapeutics [STOK] share price is $11.84. The Score for STOK is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.